Be Inspired – The Future of Medicine With Toby Walsh, Dr. Sethi, Jahnavi Phalkey & Ashish Tripathi
The future of medicine and diagnostics lies in artificial intelligence and machine learning. According to the Future Healthcare Journal, AI will be increasingly applied within the healthcare field, especially for the tasks of diagnosis and treatment recommendations, patient engagement, and administrative activities of the healthcare workforce. What does this mean for the future? Our diverse panel answers some key questions on Be Inspired,
Toby Walsh is a Laureate Fellow and Scientia Professor of AI at the University of New South Wales and Data61, and adjunct professor at QUT. He was named by an Australian newspaper as one of the "rock stars" of Australia's digital revolution. Professor Walsh is a strong advocate for limits to ensure AI is used to improve our lives. He has been a leading voice in the discussion about autonomous weapons (aka "killer robots"), speaking at the UN in New York and Geneva on the topic. He is a Fellow of the Australia Academy of Science. He appears regularly on TV and radio, and has authored two books on AI for a general audience, the most recent entitled "2062: The World that AI Made".
Dr. Tavpritesh Sethi is a physician-scientist and Associate Professor of Computational Biology at Indraprastha Institute of Information Technology Delhi, India and a fellow of the Wellcome Trust/DBT India Alliance at All India Institute of Medical Sciences, New Delhi, India. Dr. Sethi specializes in improving outcomes in neonatal, child and maternal health by bridging medicine and artificial intelligence. His research is focused on development and deployment of machine-learning based solutions to enable decisions and policy in pressing healthcare questions such as antimicrobial resistance, sepsis and health inequalities in intensive care and public health settings. He was a recipient of MIT-TR35 India Innovators under 35, Wellcome Trust/DBT India Alliance Early Career Award.
Jahnavi Phalkey was appointed Founding Director of Science Gallery Bengaluru in November 2018. Previously Jahnavi held a tenured faculty position at King’s College London. She started her academic career at the University of Heidelberg, following which she was based at Georgia Tech-Lorraine, France, and Imperial College London. Jahnavi was Fellow, Wissenschaftskolleg zu Berlin (the Institute of Advanced Study, Berlin). She was also external curator to the Science Museum London, and has been a Scholar-in-Residence at the Deutsches Museum, Munich. Jahnavi is the author of Atomic State: Big Science in Twentieth Century India.
Ashish Tripathi is the founder and CEO of Tzar Labs and Director of Epigeneres Biotech, spearheading the global launch of all major breakthroughs in molecular diagnostics achieved by the company. Prior to this, Ashish was the National Head for TMTE at Edelweiss Capital and has more than 20+ years of experience in investment banking/corporate finance, M&A and corporate strategy, business services and financial planning experience across Australia, Europe, North America, Asia including the Middle East. He has worked for a variety of MNCs, including Edelweiss, Ernst & Young, Avendus, Fairfax, Mincom, NTT Communications, Deutsche Bank and Deloitte Touché Tohmatsu.
The future of medicine and diagnostics lies in artificial intelligence and machine learning. According to the Future Healthcare Journal, AI will be increasingly applied within the healthcare field, especially for the tasks of diagnosis and treatment recommendations, patient engagement, and administrative activities of the healthcare workforce. What does this mean for the future? Our diverse panel answers some key questions on Be Inspired,
Toby Walsh is a Laureate Fellow and Scientia Professor of AI at the University of New South Wales and Data61, and adjunct professor at QUT. He was named by an Australian newspaper as one of the “rock stars” of Australia’s digital revolution. Professor Walsh is a strong advocate for limits to ensure AI is used to improve our lives. He has been a leading voice in the discussion about autonomous weapons (aka “killer robots”), speaking at the UN in New York and Geneva on the topic. He is a Fellow of the Australia Academy of Science. He appears regularly on TV and radio, and has authored two books on AI for a general audience, the most recent entitled “2062: The World that AI Made”.
Dr. Tavpritesh Sethi is a physician-scientist and Associate Professor of Computational Biology at Indraprastha Institute of Information Technology Delhi, India and a fellow of the Wellcome Trust/DBT India Alliance at All India Institute of Medical Sciences, New Delhi, India. Dr. Sethi specializes in improving outcomes in neonatal, child and maternal health by bridging medicine and artificial intelligence. His research is focused on development and deployment of machine-learning based solutions to enable decisions and policy in pressing healthcare questions such as antimicrobial resistance, sepsis and health inequalities in intensive care and public health settings. He was a recipient of MIT-TR35 India Innovators under 35, Wellcome Trust/DBT India Alliance Early Career Award.
Jahnavi Phalkey was appointed Founding Director of Science Gallery Bengaluru in November 2018. Previously Jahnavi held a tenured faculty position at King’s College London. She started her academic career at the University of Heidelberg, following which she was based at Georgia Tech-Lorraine, France, and Imperial College London. Jahnavi was Fellow, Wissenschaftskolleg zu Berlin (the Institute of Advanced Study, Berlin). She was also external curator to the Science Museum London, and has been a Scholar-in-Residence at the Deutsches Museum, Munich. Jahnavi is the author of Atomic State: Big Science in Twentieth Century India.
Ashish Tripathi is the founder and CEO of Tzar Labs and Director of Epigeneres Biotech, spearheading the global launch of all major breakthroughs in molecular diagnostics achieved by the company. Prior to this, Ashish was the National Head for TMTE at Edelweiss Capital and has more than 20+ years of experience in investment banking/corporate finance, M&A and corporate strategy, business services and financial planning experience across Australia, Europe, North America, Asia including the Middle East. He has worked for a variety of MNCs, including Edelweiss, Ernst & Young, Avendus, Fairfax, Mincom, NTT Communications, Deutsche Bank and Deloitte Touché Tohmatsu.
